I called it yesterday. This person doesn't hold, anyone holding...

First 53 Last

Share
Profile

Follow
Roddy66

218 Posts.

87

28/08/20

09:15

Post #: 46886741
Share

Originally posted by Lilo88 ↑

Just talked to PH to get the facts.

This is the PAS2424 test, this is a 24 hour abrasion test.

Zoono passed (99.9%) with flying colours after 24 hours of continuous abrasion on a surface.

PH told me out of interest they ran the continuous abrasion out to 30 days, and after 30 days abrasion Zoono remarkably was still killing at Log 2.54 (99%) against E.coli and 90% against Staphylococcus Aureus.

This is on a surface with continuous abrasion for 30 days, a far harsher environment than usual.

There is no such test as PAS2430, so it didn’t fail and Zoono did this out of sheer interest!

Also Zoono has just had a series of further tests done (as promised to Trading Standards) and all results passed against EN1500 / EN13727 / EN13697 / and EN13624.

The product has tested better than 99.99%.

They have 150 results they keep behind a PW screen because they used to be plagiarised.

Zoono are more than happy to release their test results (and they are confidential for competitive reasons) but they need to know who you are, and you need to sign an NDA – pretty standard stuff really.

Zooncats seems hellbent on creating mischief where there isn’t any. Why doesn’t he/she just call the company and talk to them?

Maybe he/she is a competitor?

Expand

I called it yesterday.

This person doesn't hold, anyone holding wouldn't so aggressively try to trash the company.

Might be wanting to hold just before any results get posted though, probably pushing for a sub $2 entry or works for the company with the 7 day claim..

ZNO Price at posting: $2.25 Sentiment: Hold Disclosure: Held
5 Upvote

0 Great analysis

Reply

Top Stories

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

NEU

Neuren sees FDA greenlight for 3rd trial into children with Phelan-McDermid syndrome

NYR

Nyrada rat study shows no genotoxicity in brain injury drug NYR-BI03

Arika to pump $3.2M into gold exploration at WA's Yundamindra following strong maiden program

CHM

Leukaemia patient shows complete response in Chimeric Therapeutics' latest trial

There are more pages in this discussion • 105 more messages in this thread...

First 53 Last

Add ZNO (ASX) to my watchlist

(20min delay)
Last 2.8¢		Change 0.003(12.0%)		Mkt cap ! $9.952M

Open	High	Low	Value	Volume
2.6¢	2.8¢	2.6¢	$3.277K	117.0K

Buyers (Bids)

No.	Vol.	Price($)
2	65824	2.7¢

Sellers (Offers)

Price($)	Vol.	No.
2.8¢	36240	1

View Market Depth

No.	Vol.	Price($)
2	65824	0.027
3	249370	0.026
3	143409	0.025
1	154528	0.024
1	39000	0.023

Price($)	Vol.	No.
0.028	36240	1
0.029	304864	1
0.030	531000	3
0.031	32096	1
0.032	139295	2

Last trade - 14.07pm 07/10/2024 (20 minute delay)

ZNO (ASX) Chart

I called it yesterday. This person doesn't hold, anyone holding...

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Neuren sees FDA greenlight for 3rd trial into children with Phelan-McDermid syndrome

Nyrada rat study shows no genotoxicity in brain injury drug NYR-BI03

Arika to pump $3.2M into gold exploration at WA's Yundamindra following strong maiden program

Leukaemia patient shows complete response in Chimeric Therapeutics' latest trial

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

I called it yesterday. This person doesn't hold, anyone holding...

Top Stories

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Neuren sees FDA greenlight for 3rd trial into children with Phelan-McDermid syndrome

Nyrada rat study shows no genotoxicity in brain injury drug NYR-BI03

Arika to pump $3.2M into gold exploration at WA's Yundamindra following strong maiden program

Leukaemia patient shows complete response in Chimeric Therapeutics' latest trial

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News